Aurora Cannabis EPS - Earnings per Share 2017-2024 | ACB
Aurora Cannabis eps - earnings per share from 2017 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Aurora Cannabis Annual EPS | |
|---|---|
| 2024 | $-1.13 |
| 2022 | $-63.15 |
| 2021 | $-32.10 |
| 2020 | $-255.10 |
| 2019 | $-26.30 |
| 2018 | $14.18 |
| 2017 | $-4.53 |
| 2017 | $0.00 |
| 2016 | $-3.60 |
| Aurora Cannabis Quarterly EPS | |
|---|---|
| 2024-12-31 | $0.41 |
| 2024-09-30 | $-0.16 |
| 2024-06-30 | $0.10 |
| 2024-03-31 | $-0.31 |
| 2023-12-31 | $-0.37 |
| 2023-09-30 | $0.00 |
| 2023-06-30 | $-0.45 |
| 2022-12-31 | $-1.48 |
| 2022-09-30 | $-1.30 |
| 2022-03-31 | $-37.27 |
| 2021-12-31 | $-3.02 |
| 2021-09-30 | $-0.48 |
| 2021-03-31 | $-8.50 |
| 2020-12-31 | $-13.37 |
| 2020-09-30 | $-6.91 |
| 2020-03-31 | $-10.22 |
| 2019-12-31 | $-107.32 |
| 2019-09-30 | $0.91 |
| 2019-03-31 | $-14.45 |
| 2018-12-31 | $-22.69 |
| 2018-09-30 | $11.02 |
| 2018-06-30 | $0.00 |
| 2018-03-31 | $-3.80 |
| 2017-12-31 | $1.89 |
| 2017-09-30 | $0.96 |
| 2017-06-30 | $3.88 |
| 2017-03-31 | $0.00 |
| 2016-12-31 | $-1.20 |
| 2016-09-30 | $-2.40 |
| 2016-06-30 | $-4.80 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.313B | $0.200B |
| Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.329B | 27.82 |
| Boston Scientific (BSX) | United States | $151.540B | 37.94 |
| Stryker (SYK) | United States | $146.015B | 30.53 |
| EssilorLuxottica (ESLOY) | France | $127.709B | 0.00 |
| Medtronic (MDT) | Ireland | $109.786B | 15.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.554B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.214B | 28.03 |
| ResMed (RMD) | United States | $36.648B | 27.53 |
| Agilent Technologies (A) | United States | $32.650B | 21.28 |
| GE HealthCare Technologies (GEHC) | United States | $32.569B | 15.46 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.464B | 88.18 |
| Koninklijke Philips (PHG) | Netherlands | $21.600B | 15.53 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.380B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.819B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.043B | 21.03 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.190B | 18.72 |
| Perrigo (PRGO) | Ireland | $3.610B | 9.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.233B | 23.84 |
| Envista Holdings (NVST) | United States | $3.178B | 26.41 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.102B | 14.46 |
| LeMaitre Vascular (LMAT) | United States | $1.865B | 41.69 |
| AtriCure (ATRC) | United States | $1.729B | 0.00 |
| Acuren (TIC) | United States | $1.228B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.101B | 24.76 |
| Neogen (NEOG) | United States | $1.077B | 13.78 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.016B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.972B | 12.42 |
| InMode (INMD) | Israel | $0.931B | 9.38 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.571B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.564B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Owens & Minor (OMI) | United States | $0.515B | 4.27 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.412B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 12.52 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Sanara MedTech (SMTI) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.61 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.198B | 52.30 |
| Omeros (OMER) | United States | $0.196B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.80 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.125B | 0.00 |
| Jin Medical (ZJYL) | China | $0.121B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.56 |
| TerrAscend (TSNDF) | Canada | $0.089B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.035B | 47.43 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |